News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,717 Results
Type
Article (8201)
Company Profile (82)
Press Release (278432)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (93646)
Career Advice (532)
Deals (16771)
Drug Delivery (10)
Drug Development (23682)
Employer Resources (35)
FDA (5186)
Job Trends (4881)
News (139292)
Policy (8969)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (621)
Accelerated approval (7)
Adcomms (5)
Allergies (29)
Alliances (19530)
ALS (58)
Alzheimer's disease (534)
Antibody-drug conjugate (ADC) (97)
Approvals (5342)
Artificial intelligence (285)
Autoimmune disease (58)
Automation (18)
Bankruptcy (113)
Best Places to Work (3801)
BIOSECURE Act (1)
Biosimilars (38)
Biotechnology (75)
Bladder cancer (48)
Brain cancer (19)
Breast cancer (260)
Cancer (1936)
Cardiovascular disease (136)
Career advice (457)
Career pathing (6)
CAR-T (101)
CDC (3)
Cell therapy (288)
Cervical cancer (11)
Clinical research (20847)
Collaboration (824)
Compensation (483)
Complete response letters (11)
COVID-19 (454)
CRISPR (55)
C-suite (462)
Cystic fibrosis (44)
Data (2432)
Denatured (2)
Depression (50)
Diabetes (140)
Diagnostics (3463)
Digital health (17)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (99)
Drug pricing (16)
Drug shortages (4)
Duchenne muscular dystrophy (70)
Earnings (45839)
Editorial (6)
Employer branding (6)
Employer resources (37)
Events (48451)
Executive appointments (545)
FDA (6409)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (619)
Gene editing (118)
Generative AI (18)
Gene therapy (186)
GLP-1 (205)
Government (633)
Guidances (231)
Healthcare (7285)
HIV (11)
Huntington's disease (13)
IgA nephropathy (20)
Immunology and inflammation (77)
Immuno-oncology (14)
Indications (37)
Infectious disease (496)
Inflammatory bowel disease (75)
Inflation Reduction Act (3)
Influenza (11)
Intellectual property (75)
Interviews (63)
IPO (8688)
IRA (5)
Job creations (1213)
Job search strategy (409)
JPM (7)
Kidney cancer (10)
Labor market (11)
Layoffs (122)
Leadership (6)
Legal (2527)
Liver cancer (31)
Longevity (5)
Lung cancer (205)
Lymphoma (97)
Machine learning (22)
Management (12)
Manufacturing (250)
MASH (71)
Medical device (5749)
Medtech (5766)
Mergers & acquisitions (8617)
Metabolic disorders (325)
Multiple sclerosis (56)
NASH (6)
Neurodegenerative disease (118)
Neuropsychiatric disorders (24)
Neuroscience (1000)
NextGen: Class of 2026 (2216)
Non-profit (1121)
Now hiring (10)
Obesity (111)
Opinion (55)
Ovarian cancer (45)
Pain (68)
Pancreatic cancer (77)
Parkinson's disease (98)
Partnered (10)
Patents (146)
Patient recruitment (186)
Peanut (18)
People (28803)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase 1 (6697)
Phase 2 (9161)
Phase 3 (6882)
Pipeline (2735)
Policy (27)
Postmarket research (719)
Preclinical (2775)
Press Release (69)
Prostate cancer (122)
Psychedelics (3)
Radiopharmaceuticals (170)
Rare diseases (273)
Real estate (2173)
Recruiting (8)
Regulatory (7121)
Reports (23)
Research institute (662)
Resumes & cover letters (77)
Rett syndrome (20)
RNA editing (2)
RSV (3)
Schizophrenia (64)
Series A (114)
Series B (99)
Sickle cell disease (37)
Special edition (3)
Spinal muscular atrophy (37)
Sponsored (14)
Startups (1336)
State (1)
Stomach cancer (3)
Supply chain (24)
Tariffs (7)
The Weekly (3)
Vaccines (129)
Venture capital (18)
Weight loss (45)
Women's health (18)
Date
Last 7 days (240)
Last 30 days (927)
Last 365 days (13535)
2026 (1275)
2025 (13820)
2024 (15848)
2023 (17986)
2022 (24190)
2021 (25077)
2020 (22719)
2019 (17123)
2018 (13021)
2017 (12780)
2016 (11558)
2015 (14621)
2014 (11200)
2013 (9054)
2012 (9584)
2011 (10096)
2010 (9657)
Location
Africa (225)
Alabama (44)
Alaska (2)
Arizona (101)
Arkansas (4)
Asia (14600)
Australia (2065)
California (5446)
Canada (1521)
China (379)
Colorado (223)
Connecticut (230)
Delaware (115)
Europe (33274)
Florida (805)
Georgia (102)
Hawaii (2)
Idaho (36)
Illinois (312)
India (18)
Indiana (177)
Iowa (12)
Japan (210)
Kansas (87)
Kentucky (19)
Louisiana (15)
Maine (56)
Maryland (508)
Massachusetts (4173)
Michigan (136)
Minnesota (251)
Mississippi (1)
Missouri (75)
Montana (20)
Nebraska (15)
Nevada (52)
New Hampshire (35)
New Jersey (1283)
New Mexico (15)
New York (1112)
North Carolina (749)
North Dakota (4)
Northern California (2762)
Ohio (177)
Oklahoma (7)
Oregon (12)
Pennsylvania (815)
Puerto Rico (5)
Rhode Island (24)
South America (331)
South Carolina (52)
Southern California (2089)
Tennessee (88)
Texas (824)
United States (18300)
Utah (225)
Vermont (1)
Virginia (125)
Washington D.C. (23)
Washington State (360)
West Virginia (3)
Wisconsin (72)
Wyoming (1)
286,717 Results for "precision optics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025
November 6, 2025
·
4 min read
Press Releases
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
September 29, 2025
·
16 min read
Press Releases
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
August 18, 2025
·
3 min read
Press Releases
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
May 16, 2025
·
13 min read
Press Releases
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
May 27, 2025
·
4 min read
Business
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced that it has scheduled a conference call to discuss third quarter of fiscal year 2024 financial results on Wednesday, May 15, 2024, at 5:00pm ET.
May 8, 2024
·
3 min read
Business
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results
Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024.
May 15, 2024
·
12 min read
Press Releases
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
January 29, 2026
·
3 min read
Press Releases
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
March 20, 2025
·
5 min read
Genetown
Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application
Precision Optics Corporation, Inc. announced it has received a $720,000 follow on production order from a top tier defense/aerospace company addressing a commercial application that leverages the Company’s proprietary manufacturing technology developed for high precision micro-optics systems.
April 18, 2024
·
3 min read
1 of 28,672
Next
